Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.03+0.03 (+3.00%)
Close on Nov 18, 2026Market cap $36.48MP/E –Yield –
Skye Bioscience pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Skye Bioscience's pe ratio was 5.5× on Jul 31, 2020.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Jul 31, 2020 | 5.5× | – |
See a number that looks wrong?